Trial Details
RECRUITINGBasic Information
| Clinical ID | c1613 |
|---|---|
| Identifier | NCT06588855 |
| Trial Title | A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderately to Severely Active Ulcerative Colitis |
| Interventions | DRUG: RO7790121|DRUG: Placebo |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Scottsdale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-12-11 |
|---|---|
| Primary Completion Date | 2027-06-30 |
| Completion Date | 2029-12-30 |